CN105395514A - Zhonghua ganling capsule and preparation method thereof - Google Patents
Zhonghua ganling capsule and preparation method thereof Download PDFInfo
- Publication number
- CN105395514A CN105395514A CN201510879031.3A CN201510879031A CN105395514A CN 105395514 A CN105395514 A CN 105395514A CN 201510879031 A CN201510879031 A CN 201510879031A CN 105395514 A CN105395514 A CN 105395514A
- Authority
- CN
- China
- Prior art keywords
- radix
- capsule
- ganling
- zhonghua
- vinegar system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000021419 vinegar Nutrition 0.000 claims abstract description 25
- 239000000052 vinegar Substances 0.000 claims abstract description 25
- 238000001035 drying Methods 0.000 claims abstract description 19
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 15
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000000227 grinding Methods 0.000 claims abstract description 8
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 8
- 210000004185 liver Anatomy 0.000 claims description 35
- 239000006071 cream Substances 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 21
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 14
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 229930195725 Mannitol Natural products 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 8
- 238000004132 cross linking Methods 0.000 claims description 8
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 8
- 235000019359 magnesium stearate Nutrition 0.000 claims description 8
- 239000000594 mannitol Substances 0.000 claims description 8
- 235000010355 mannitol Nutrition 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 206010013786 Dry skin Diseases 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 238000005550 wet granulation Methods 0.000 claims description 7
- 208000002193 Pain Diseases 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 230000036407 pain Effects 0.000 claims description 6
- 206010012735 Diarrhoea Diseases 0.000 claims description 5
- 208000022531 anorexia Diseases 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 206010061428 decreased appetite Diseases 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 6
- 241000382455 Angelica sinensis Species 0.000 abstract description 2
- 244000183685 Citrus aurantium Species 0.000 abstract description 2
- 240000002505 Pogostemon cablin Species 0.000 abstract description 2
- 235000011751 Pogostemon cablin Nutrition 0.000 abstract description 2
- 244000294611 Punica granatum Species 0.000 abstract description 2
- 235000014360 Punica granatum Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 230000008092 positive effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 4
- 230000010354 integration Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000202726 Bupleurum Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241000219991 Lythraceae Species 0.000 description 1
- 241001673966 Magnolia officinalis Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241001482311 Trionychidae Species 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Zhonghua ganling capsule and a preparation method thereof. The Zhonghua ganling capsule is characterized by being prepared from the following medicinal materials by weight: 222g of pogostemon cablin, 111g of pomegranate bark, 60g of radix bupleuri (processed with vinegar), 300g of mangnolia officinalis (processed with ginger), 40g of pseudo-ginseng, 333g of radix angelica sinensis, 111g of rhizoma chuanxiong, 200g of turtle shell (processed with vinegar), 180g of radix curcumae, 333g of pericarpium citri reticulatae viride (processed with vinegar), and 270g of immature bitter orange (stir-fried with bran). The preparation method comprises the following steps: extracting by adopting a carbon dioxide supercritical extraction method, carrying out drying under reduced pressure, grinding by adopting a high-energy nanometer impact mill to obtain dry nanometer paste, and adding functional auxiliary materials into the dry nanometer paste, thus preparing the Zhonghua ganling capsule. The Zhonghua ganling capsule and the preparation method have the advantages that the disintegration time is obviously shortened, the curative effect of the Zhonghua ganling capsule is obviously superior to that of the commercially available Zhonghua ganling capsule, and positive effects are achieved.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese liver curing capsule and preparation method thereof.
Background technology
China's liver curing capsule the liver soothing and the spleen invigorating, regulating QI to relieve pain, blood blood stasis dispelling in living, hard masses softening and resolving.For the resistance of stagnation of QI due to depression of the liver blood, gather and do not disappear, two side of body distending pains, anorexia and loose stool, tongue has cold speckle, the unable person of deep and hesitant pulse.Commercially available Chinese liver curing capsule is due to prescription and technological reason, and curative effect is not satisfactory, and preparation adopts traditional handicraft preparation, there is the deficiencies such as prolonged disintegration, curative effect are low.
Summary of the invention
The present invention, for overcoming above-mentioned deficiency, provides Chinese liver curing capsule that a kind of disintegration rate is fast, curative effect is high and preparation method thereof.
Invention embodiment is as follows:
Get Herba Pogostemonis 222g, Pericarpium Granati 111g, Radix Bupleuri (vinegar system) 60g, Cortex Magnoliae Officinalis (processed with Rhizoma Zingiberis Recens) 300g, Radix Notoginseng 40g, Radix Angelicae Sinensis 333g, Rhizoma Chuanxiong 111g, Carapax Trionycis (vinegar system) 200g, Radix Curcumae 180g, Pericarpium Citri Reticulatae Viride (vinegar system) 333g, Fructus Aurantii Immaturus (parched with bran) 270g, be ground into 60 order coarse powder, employing carbon dioxide supercritical extraction method is extracted, extracting pressure 19 ~ 40Mpa, extraction temperature 15 ~ 43 DEG C, separator pressure 11 ~ 19Mpa, separator temperature 35 ~ 60 DEG C, disengaging time 2.6 ~ 3.4 hours, carbon dioxide flow 24 ~ 36L per hour, obtains extracting solution; Get extracting solution 61 ~ 75 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add mannitol 150 ~ 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 45 ~ 55g, crospolyvinylpyrrolidone 45 ~ 55g, cross-linking sodium carboxymethyl cellulose 35 ~ 45g, mix homogeneously, with 50 ~ 70% ethanol wet granulations, 60 DEG C ~ 80 DEG C dryings, additional carboxymethyl starch sodium 7 ~ 9g, magnesium stearate 1 ~ 3g, granulate, incapsulates, obtained Chinese liver curing capsule 1700.
The raw material standards that above-mentioned embodiment is mentioned is as follows:
Herba Pogostemonis: China's coastal port one ministerial standard.This product is that labiate extensively stores fragrant Pogostemoncablin(Blanco) dry aerial parts of Benth..Tap when branch and leaf are luxuriant, Exposure to Sunlight is vexed for night, repeatedly to dry.
Pericarpium Granati: China's coastal port one ministerial standard.This product is the dry peel of Punicaceae plant Punica granatum L. PunicagranatumL..Autumn collects peel after fruit maturation, dries.
Radix Bupleuri: China's coastal port one ministerial standard.This product is the dry root of umbelliferae bupleurum BupleurumchinenseDC. or Radix Bupeuri Scorzonerfolii. BupleurumscocrzonerifoliumWilld..Different by character, practise title " Radix Bupleuri " and " Radix Bupleuri Scorzonerifolii " respectively.Spring, Qiu Erji excavate, removing stem and leaf and silt, dry.
Cortex Magnoliae Officinalis: China's coastal port one ministerial standard.This product is the dry dried bark of Magnoliacea plant Cortex Magnoliae Officinalis MignoliaofficinalisRehd.etWils. or magnolia officinalis rehd.et wils.var.biloba rehd.et wils. MignoliaofficinalisRehd.etWils.var.bilobaRehdetWils., root bark and branch skin.The 4-6 month strips, root bark and branch skin Directly Dried in Shadow; In skin put in boiling water micro-boil after, dark and damp place of banking up, when " diaphoresis " is to inner surface purpling brown or sepia, steams soft, takes out, is rolled into tubular, dry.
Radix Notoginseng: China's coastal port one ministerial standard.This product is the dry root and rhizome of panax araliaceae plant Punaxnotoginseng (Burk.) F.H.Chen.Autumn excavates before the flowers are in blossom, cleans, and separately main root, a root and rhizome, dry.Supporting root is practised and is claimed " rib ", and rhizome is practised and claimed " clip ".
Radix Angelicae Sinensis: China's coastal port one ministerial standard.This product is umbelliferae angelica Angelicasinensis(Oliv.) dry root of Diels.Autumn end excavates, and removing fibrous root and silt, after moisture slightly evaporates, be bundled into wisp, upper canopy, with pyrotechnics slowly smoke-dried beancurd.
Rhizoma Chuanxiong: China's coastal port one ministerial standard.This product is the dry rhizome of samphire Rhizoma Chuanxiong LigusticumchuanriongHort..The joint dish that summer works as on stem is significantly outstanding, and excavates during purplish, and removing silt, shines post-drying, then remove fibrous root.
Carapax Trionycis: China's coastal port one ministerial standard.This product is the carapace of Trionychidae animal Trionyx sinensis Wiegmann TrionyxsinensisWiegmann.The whole year all can catch, and is many, kills after seizure with autumn, season in winter two, puts in boiling water and scalds when can peel off to the sclerderm on carapace, takes out, strips carapace, remove residual meat, dry.
Radix Curcumae: China's coastal port one ministerial standard.This product is the dried root of zingiberaceous plant RADIX CURCUMAE CurcumawenyujinY.H.ChenetC.Ling, Rhizoma Curcumae Longae CurcumalongaL., Guangxi zedoary CurcumakwaugsienisS.G.LeeetC.F.Liang or Rhizoma Curcumae Curcumapha-eocaulisVal..The above two practise title " RADIX CURCUMAE " and " Radix Curcuma " respectively, and all the other are practised by character difference and claim " osmanthus Radix Curcumae " or " green filament Radix Curcumae ".Winter, stem and leaf was excavated after withering, and removing silt and radicula, steam or boil to the saturating heart, dry.
Pericarpium Citri Reticulatae Viride: China's coastal port one ministerial standard.This product is the dry young fruit of rutaceae orange CitrusreticulataBlanco and variety thereof or the peel of immature fruit.Collecting the young fruit from falling the 5-6 month, drying, practise and claim " FTUCTUS CITRI IMMATURI "; Gather the 7-8 month green fruit, on peel, vertical profile becomes pintongs to base portion, eliminates flesh lobe, dries, and practises and claims " Sihuaqingpi ".
Fructus Aurantii Immaturus: China's coastal port one ministerial standard.This product is the dry young fruit of rutaceae Citrus aurantium Linn. CitrusaurantiumL. and variety or Fructus Citri sinensis CitrussinensisOsbeck.Collect the fruit from falling the 5-6 month, removing impurity, be two halves from middle part crosscut, dry or cold drying, smaller directly dries or cold drying.
Mannitol: Chinese Pharmacopoeia version two ministerial standard in 2010.
Microcrystalline Cellulose: Chinese Pharmacopoeia version two ministerial standard in 2010.
Crospolyvinylpyrrolidone: Chinese Pharmacopoeia version two ministerial standard in 2010.
Cross-linking sodium carboxymethyl cellulose: Chinese Pharmacopoeia version two ministerial standard in 2010.
Carboxymethyl starch sodium: Chinese Pharmacopoeia version two ministerial standard in 2010.
Magnesium stearate: Chinese Pharmacopoeia version two ministerial standard in 2010.
Raw material used by above Chinese liver curing capsule all can be bought from pharmaceuticals and obtain, and all can be used to implement the present invention program as long as meet national standard.
In foregoing invention scheme, term used is pharmacy proprietary term, as " decompression ", " vinegar system ", " processed with Rhizoma Zingiberis Recens " etc. all defer to Chinese Pharmacopoeia regulation and pharmaceutical practice of being correlated with.
Unit g in the present invention also can be other weight portion, does not affect the enforcement of the present invention program.
Equipment Market described in the present invention program all has sale, is not limited to typical production producer, as long as technical specification can reach requirement, all can be used to realize the present invention.
Four detailed description of the invention
Specific embodiments of the invention 1
Get Herba Pogostemonis 222g, Pericarpium Granati 111g, Radix Bupleuri (vinegar system) 60g, Cortex Magnoliae Officinalis (processed with Rhizoma Zingiberis Recens) 300g, Radix Notoginseng 40g, Radix Angelicae Sinensis 333g, Rhizoma Chuanxiong 111g, Carapax Trionycis (vinegar system) 200g, Radix Curcumae 180g, Pericarpium Citri Reticulatae Viride (vinegar system) 333g, Fructus Aurantii Immaturus (parched with bran) 270g, be ground into 60 order coarse powder, adopt carbon dioxide supercritical extraction method to extract, extracting pressure 19Mpa, extraction temperature 15 DEG C, separator pressure 11Mpa, separator temperature 35 DEG C, disengaging time 2.6 hours, carbon dioxide flow 24L per hour, obtains extracting solution; Get extracting solution 61 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add mannitol 150g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 45g, crospolyvinylpyrrolidone 45g, cross-linking sodium carboxymethyl cellulose 35g, mix homogeneously, with 50% ethanol wet granulation, 60 DEG C of dryings, additional carboxymethyl starch sodium 7g, magnesium stearate 1g, granulate, incapsulates, obtained Chinese liver curing capsule 1700.
Specific embodiments of the invention 2
Get Herba Pogostemonis 222g, Pericarpium Granati 111g, Radix Bupleuri (vinegar system) 60g, Cortex Magnoliae Officinalis (processed with Rhizoma Zingiberis Recens) 300g, Radix Notoginseng 40g, Radix Angelicae Sinensis 333g, Rhizoma Chuanxiong 111g, Carapax Trionycis (vinegar system) 200g, Radix Curcumae 180g, Pericarpium Citri Reticulatae Viride (vinegar system) 333g, Fructus Aurantii Immaturus (parched with bran) 270g, be ground into 60 order coarse powder, adopt carbon dioxide supercritical extraction method to extract, extracting pressure 40Mpa, extraction temperature 43 DEG C, separator pressure 19Mpa, separator temperature 60 DEG C, disengaging time 3.4 hours, carbon dioxide flow 36L per hour, obtains extracting solution; Get extracting solution 75 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add mannitol 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 55g, crospolyvinylpyrrolidone 55g, cross-linking sodium carboxymethyl cellulose 45g, mix homogeneously, with 70% ethanol wet granulation, 80 DEG C of dryings, additional carboxymethyl starch sodium 9g, magnesium stearate 3g, granulate, incapsulates, obtained Chinese liver curing capsule 1700.
Specific embodiments of the invention 3
Get Herba Pogostemonis 222g, Pericarpium Granati 111g, Radix Bupleuri (vinegar system) 60g, Cortex Magnoliae Officinalis (processed with Rhizoma Zingiberis Recens) 300g, Radix Notoginseng 40g, Radix Angelicae Sinensis 333g, Rhizoma Chuanxiong 111g, Carapax Trionycis (vinegar system) 200g, Radix Curcumae 180g, Pericarpium Citri Reticulatae Viride (vinegar system) 333g, Fructus Aurantii Immaturus (parched with bran) 270g, be ground into 60 order coarse powder, adopt carbon dioxide supercritical extraction method to extract, extracting pressure 30Mpa, extraction temperature 29 DEG C, separator pressure 15Mpa, separator temperature 48 DEG C, disengaging time 3 hours, carbon dioxide flow 30L per hour, obtains extracting solution; Get extracting solution 68 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add mannitol 175g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 50g, crospolyvinylpyrrolidone 50g, cross-linking sodium carboxymethyl cellulose 40g, mix homogeneously, with 60% ethanol wet granulation, 70 DEG C of dryings, additional carboxymethyl starch sodium 8g, magnesium stearate 2g, granulate, incapsulates, obtained Chinese liver curing capsule 1700.
Above embodiment illustrates, adopts the extreme condition of embodiment of the present invention and optimal conditions all can make Chinese liver curing capsule.Actual effect of the present invention is investigated below with the Chinese liver curing capsule that embodiment 3 is obtained:
(1) embodiment 3 Chinese liver curing capsule and contrast disintegration of commercially available Chinese liver curing capsule
1 disintegration time mensuration method
Measure by Chinese Pharmacopoeia version annex Ⅻ A in 2010.
Contrast 2 disintegrations
Table 1 embodiment 3 Chinese liver curing capsule and commercially available Chinese liver curing capsule contrast table disintegration
The above results shows, Chinese liver curing capsule prepared by the present invention has the remarkable advantages such as disintegration rate is fast, bioavailability is high relative to commercially available Chinese liver curing capsule.
(2) embodiment 3 Chinese liver curing capsule and the resistance of commercially available Chinese liver curing capsule treatment stagnation of QI due to depression of the liver blood, gather and do not disappear, two side of body distending pains, anorexia and loose stool, tongue has cold speckle, the unable clinical observation on the therapeutic effect of deep and hesitant pulse
1 case scenario
Statistics outpatient service and inpatient, observe the resistance of stagnation of QI due to depression of the liver blood altogether, gather and do not disappear, two side of body distending pains, anorexia and loose stool, and tongue has cold speckle, unable case 128 example of deep and hesitant pulse, 45 years old mean age.Patient is divided into two groups, test group takes the Chinese liver curing capsule of embodiment 3, and matched group takes commercially available Chinese liver curing capsule.
2 efficacy assessment standards
According to new Chinese medicine treatment guideline of clinical investigations tcm syndrome curative effect determinate standard:
Clinical recovery: tcm clinical practice symptom, sign disappear or substantially disappear, syndrome integral reduces >=95%.
Effective: tcm clinical practice symptom, sign are obviously improved, syndrome integral reduces >=70%.
Effective: tcm clinical practice symptom, sign all take a favorable turn, syndrome integral reduces >=30%.
Invalid: tcm clinical practice symptom, sign are all not improved or increase the weight of, syndrome integral reduces < 30%.
Computing formula: [before (before treatment the rear integration of integration-treatment) ÷ treatment integration] × 100%.
3 clinical observation result
Table 2 embodiment 3 Chinese liver curing capsule and commercially available Chinese liver curing capsule clinical efficacy contrast table
Above-mentioned clinical observation on the therapeutic effect result shows, Chinese liver curing capsule prepared by the present invention, in the resistance for the treatment of stagnation of QI due to depression of the liver blood, gathers and do not disappear, two side of body distending pains, anorexia and loose stool, tongue has cold speckle, when deep and hesitant pulse is unable, evident in efficacy higher than commercially available Chinese liver curing capsule, p < 0.05.
Claims (3)
1. treatment stagnation of QI due to depression of the liver blood resistance, gather and do not disappear, two side of body distending pains, anorexia and loose stool, tongue has cold speckle, the Chinese medicine that deep and hesitant pulse is unable, it is characterized in that getting Herba Pogostemonis 222g, Pericarpium Granati 111g, Radix Bupleuri (vinegar system) 60g, Cortex Magnoliae Officinalis (processed with Rhizoma Zingiberis Recens) 300g, Radix Notoginseng 40g, Radix Angelicae Sinensis 333g, Rhizoma Chuanxiong 111g, Carapax Trionycis (vinegar system) 200g, Radix Curcumae 180g, Pericarpium Citri Reticulatae Viride (vinegar system) 333g, Fructus Aurantii Immaturus (parched with bran) 270g, be ground into 60 order coarse powder, employing carbon dioxide supercritical extraction method is extracted, extracting pressure 19 ~ 40Mpa, extraction temperature 15 ~ 43 DEG C, separator pressure 11 ~ 19Mpa, separator temperature 35 ~ 60 DEG C, disengaging time 2.6 ~ 3.4 hours, carbon dioxide flow 24 ~ 36L per hour, obtain extracting solution, get extracting solution 61 ~ 75 DEG C of drying under reduced pressure, get dry extract, get dry cream and add mannitol 150 ~ 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm, get mixing dried cream powder, microcrystalline Cellulose 45 ~ 55g, crospolyvinylpyrrolidone 45 ~ 55g, cross-linking sodium carboxymethyl cellulose 35 ~ 45g, mix homogeneously, with 50 ~ 70% ethanol wet granulations, 60 DEG C ~ 80 DEG C dryings, additional carboxymethyl starch sodium 7 ~ 9g, magnesium stearate 1 ~ 3g, granulate, incapsulates, obtained Chinese liver curing capsule.
2. the preparation method of Chinese medicine according to claim 1, it is characterized in that getting Herba Pogostemonis 222g, Pericarpium Granati 111g, Radix Bupleuri (vinegar system) 60g, Cortex Magnoliae Officinalis (processed with Rhizoma Zingiberis Recens) 300g, Radix Notoginseng 40g, Radix Angelicae Sinensis 333g, Rhizoma Chuanxiong 111g, Carapax Trionycis (vinegar system) 200g, Radix Curcumae 180g, Pericarpium Citri Reticulatae Viride (vinegar system) 333g, Fructus Aurantii Immaturus (parched with bran) 270g, be ground into 60 order coarse powder, employing carbon dioxide supercritical extraction method is extracted, extracting pressure 19 ~ 40Mpa, extraction temperature 15 ~ 43 DEG C, separator pressure 11 ~ 19Mpa, separator temperature 35 ~ 60 DEG C, disengaging time 2.6 ~ 3.4 hours, carbon dioxide flow 24 ~ 36L per hour, obtain extracting solution, get extracting solution 61 ~ 75 DEG C of drying under reduced pressure, get dry extract, get dry cream and add mannitol 150 ~ 200g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm, get mixing dried cream powder, microcrystalline Cellulose 45 ~ 55g, crospolyvinylpyrrolidone 45 ~ 55g, cross-linking sodium carboxymethyl cellulose 35 ~ 45g, mix homogeneously, with 50 ~ 70% ethanol wet granulations, 60 DEG C ~ 80 DEG C dryings, additional carboxymethyl starch sodium 7 ~ 9g, magnesium stearate 1 ~ 3g, granulate, incapsulates, obtained Chinese liver curing capsule.
3. the preparation method of Chinese medicine according to claim 1, gets Herba Pogostemonis 222g, Pericarpium Granati 111g, Radix Bupleuri (vinegar system) 60g, Cortex Magnoliae Officinalis (processed with Rhizoma Zingiberis Recens) 300g, Radix Notoginseng 40g, Radix Angelicae Sinensis 333g, Rhizoma Chuanxiong 111g, Carapax Trionycis (vinegar system) 200g, Radix Curcumae 180g, Pericarpium Citri Reticulatae Viride (vinegar system) 333g, Fructus Aurantii Immaturus (parched with bran) 270g, be ground into 60 order coarse powder, adopt carbon dioxide supercritical extraction method to extract, extracting pressure 30Mpa, extraction temperature 29 DEG C, separator pressure 15Mpa, separator temperature 48 DEG C, disengaging time 3 hours, carbon dioxide flow 30L per hour, obtains extracting solution; Get extracting solution 68 DEG C of drying under reduced pressure, get dry extract; Get dry cream and add mannitol 175g, adopt the impact grinding of high energy nanometer to be ground into the mixing dried cream powder of particle diameter 200 ~ 300nm; Get mixing dried cream powder, microcrystalline Cellulose 50g, crospolyvinylpyrrolidone 50g, cross-linking sodium carboxymethyl cellulose 40g, mix homogeneously, with 60% ethanol wet granulation, 70 DEG C of dryings, additional carboxymethyl starch sodium 8g, magnesium stearate 2g, granulate, incapsulates, obtained Chinese liver curing capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510879031.3A CN105395514A (en) | 2015-12-05 | 2015-12-05 | Zhonghua ganling capsule and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510879031.3A CN105395514A (en) | 2015-12-05 | 2015-12-05 | Zhonghua ganling capsule and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105395514A true CN105395514A (en) | 2016-03-16 |
Family
ID=55461514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510879031.3A Pending CN105395514A (en) | 2015-12-05 | 2015-12-05 | Zhonghua ganling capsule and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105395514A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3400932A1 (en) * | 2017-05-08 | 2018-11-14 | mcePharma s. r. o. | Mixture of stabilised biologically available curcumin for orodispersible formulations, formulations of biologically available curcumin, and an orodispersible tablet with biologically available curcumin, and its application |
-
2015
- 2015-12-05 CN CN201510879031.3A patent/CN105395514A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3400932A1 (en) * | 2017-05-08 | 2018-11-14 | mcePharma s. r. o. | Mixture of stabilised biologically available curcumin for orodispersible formulations, formulations of biologically available curcumin, and an orodispersible tablet with biologically available curcumin, and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105395514A (en) | Zhonghua ganling capsule and preparation method thereof | |
| CN105381402A (en) | Qi-regulating and heart-soothing tablet and preparation method thereof | |
| CN105708938A (en) | Haemorrhoid tablet and preparation method thereof | |
| CN105343210A (en) | Spur pill and preparation method thereof | |
| CN104398951A (en) | Stomachache tablet and preparation method thereof | |
| CN105456700A (en) | Kidney-tonifying bone-supplementing capsule and preparation method thereof | |
| CN105381407A (en) | Qi regulating and heart soothing tablet and preparation method thereof | |
| CN104224945A (en) | Hepatitis B body-resistance-strengthening capsule and preparation method thereof | |
| CN105434977A (en) | Huoxiang Zhengqi capsule and preparation method thereof | |
| CN105362948A (en) | Tablets for treating traumatic injuries and preparation method thereof | |
| CN104127828A (en) | Guangmaining tablet and preparation method thereof | |
| CN105412028A (en) | Lipid-lowering tablet and preparation method thereof | |
| CN105343677A (en) | Embolism eliminating and collateral dredging capsules and preparing method thereof | |
| CN105343632A (en) | Brain-strengthening capsules and preparing method thereof | |
| CN105343681A (en) | Cough-relieving exocarpium citri grandis capsules and preparation method thereof | |
| CN104383037A (en) | Anti-cerebral-thrombosis tablets and preparation method thereof | |
| CN104474020A (en) | Nose-ventilating tablet and preparation method thereof | |
| CN105770584A (en) | Heart calming tablet and preparation method thereof | |
| CN105343788A (en) | Embolism eliminating and collateral dredging tablets and preparing method thereof | |
| CN105343730A (en) | Capsule for treating ulcers and preparation method thereof | |
| CN105362344A (en) | Hongyao tablet and preparation method thereof | |
| CN104224956A (en) | Mind-calming tablet and preparation method thereof | |
| CN105362393A (en) | Fengtongning tablet and preparation method thereof | |
| CN105343527A (en) | Naolingsu capsules and preparation method thereof | |
| CN105497745A (en) | Liver-soothing tablets and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160316 |
|
| WD01 | Invention patent application deemed withdrawn after publication |